Zum Hauptinhalt springen

Medical history, lifestyle, family history, and occupational risk factors for lymphoplasmacytic lymphoma/Waldenström's macroglobulinemia: the InterLymph Non-Hodgkin Lymphoma Subtypes Project.

Vajdic, CM ; Landgren, O ; et al.
In: Journal of the National Cancer Institute. Monographs, Jg. 2014 (2014-08-01), Heft 48, S. 87-97
Online academicJournal

Titel:
Medical history, lifestyle, family history, and occupational risk factors for lymphoplasmacytic lymphoma/Waldenström's macroglobulinemia: the InterLymph Non-Hodgkin Lymphoma Subtypes Project.
Autor/in / Beteiligte Person: Vajdic, CM ; Landgren, O ; McMaster, ML ; Slager, SL ; Brooks-Wilson, A ; Smith, A ; Staines, A ; Dogan, A ; Ansell, SM ; Sampson, JN ; Morton, LM ; Linet, MS
Link:
Zeitschrift: Journal of the National Cancer Institute. Monographs, Jg. 2014 (2014-08-01), Heft 48, S. 87-97
Veröffentlichung: <2003-> : Cary Nc : Oxford University Press ; <i>Original Publication</i>: Bethesda, MD : U.S. Dept. of Health and Human Services, Public Health Service, National Institutes of Health ; Washington, DC : For sale by the Supt. of Docs., U.S. G.P.O., [1990-, 2014
Medientyp: academicJournal
ISSN: 1745-6614 (electronic)
DOI: 10.1093/jncimonographs/lgu002
Schlagwort:
  • Adult
  • Aged
  • Aged, 80 and over
  • Australia epidemiology
  • Australia ethnology
  • Case-Control Studies
  • Comorbidity
  • Europe epidemiology
  • Europe ethnology
  • Female
  • Humans
  • Male
  • Middle Aged
  • North America epidemiology
  • North America ethnology
  • Risk Factors
  • Young Adult
  • Life Style
  • Occupational Exposure
  • Waldenstrom Macroglobulinemia epidemiology
  • Waldenstrom Macroglobulinemia etiology
Sonstiges:
  • Nachgewiesen in: MEDLINE
  • Sprachen: English
  • Publication Type: Journal Article; Meta-Analysis; Research Support, N.I.H., Extramural; Research Support, N.I.H., Intramural; Research Support, Non-U.S. Gov't
  • Language: English
  • [J Natl Cancer Inst Monogr] 2014 Aug; Vol. 2014 (48), pp. 87-97.
  • MeSH Terms: Life Style* ; Occupational Exposure* ; Waldenstrom Macroglobulinemia / *epidemiology ; Waldenstrom Macroglobulinemia / *etiology ; Adult ; Aged ; Aged, 80 and over ; Australia / epidemiology ; Australia / ethnology ; Case-Control Studies ; Comorbidity ; Europe / epidemiology ; Europe / ethnology ; Female ; Humans ; Male ; Middle Aged ; North America / epidemiology ; North America / ethnology ; Risk Factors ; Young Adult
  • References: J Leukoc Biol. 2011 Dec;90(6):1065-78. (PMID: 21878544) ; JAMA. 2007 May 9;297(18):2010-7. (PMID: 17488966) ; Blood. 2003 Nov 15;102(10):3759-64. (PMID: 12881316) ; Clin Exp Immunol. 2012 Nov;170(2):231-7. (PMID: 23039894) ; Arch Intern Med. 2008 Sep 22;168(17):1903-9. (PMID: 18809818) ; Int J Mol Epidemiol Genet. 2011;2(2):95-113. (PMID: 21686124) ; Rheumatology (Oxford). 2007 Jan;46(1):37-43. (PMID: 16735452) ; Cancer. 1996 Jun 15;77(12):2604-13. (PMID: 8640712) ; Br J Cancer. 2013 Jun 11;108(11):2390-8. (PMID: 23640394) ; Blood. 2008 Oct 15;112(8):3052-6. (PMID: 18703425) ; Int J Cancer. 2008 May 1;122(9):2062-70. (PMID: 18167059) ; Blood. 1994 Jun 15;83(12):3647-53. (PMID: 8204889) ; J Natl Cancer Inst. 2010 Apr 21;102(8):557-67. (PMID: 20181958) ; Int J Cancer. 2004 Jun 20;110(3):429-34. (PMID: 15095310) ; Cancer Epidemiol Biomarkers Prev. 2004 Sep;13(9):1415-21. (PMID: 15342441) ; Trends Immunol. 2010 Oct;31(10):384-90. (PMID: 20817556) ; Cancer Causes Control. 2003 Sep;14(7):687-94. (PMID: 14575367) ; Stat Med. 2002 Jun 15;21(11):1539-58. (PMID: 12111919) ; Int J Cancer. 2004 Jun 20;110(3):380-5. (PMID: 15095303) ; J Virol. 2005 Jul;79(13):8079-89. (PMID: 15956553) ; Blood. 2006 Jan 1;107(1):265-76. (PMID: 16150940) ; Int J Cancer. 2007 Dec 15;121(12):2767-75. (PMID: 17722095) ; Am J Epidemiol. 1999 Aug 15;150(4):375-89. (PMID: 10453814) ; Ann Oncol. 2006 Mar;17(3):488-94. (PMID: 16357024) ; Blood. 1995 Apr 1;85(7):1913-9. (PMID: 7703494) ; Blood. 2010 Jun 3;115(22):4464-71. (PMID: 20308603) ; J Neuroimmunol. 1998 Mar 15;83(1-2):148-56. (PMID: 9610683) ; Cancer Prev Res (Phila). 2013 Aug;6(8):864-73. (PMID: 23803416) ; PLoS One. 2011 Mar 23;6(3):e17154. (PMID: 21448265) ; Leukemia. 1993 Sep;7(9):1363-9. (PMID: 8371587) ; Curr Opin Oncol. 2006 Sep;18(5):417-24. (PMID: 16894287) ; J Natl Cancer Inst. 2005 Feb 2;97(3):199-209. (PMID: 15687363) ; Br J Haematol. 2009 Aug;146(4):418-23. (PMID: 19573080) ; Br J Haematol. 2005 Mar;128(5):610-5. (PMID: 15725081) ; Cancer Epidemiol Biomarkers Prev. 2005 Apr;14(4):925-33. (PMID: 15824165) ; Blood. 2006 Oct 15;108(8):2755-63. (PMID: 16804116) ; Int J Cancer. 2006 Aug 15;119(4):901-8. (PMID: 16557575) ; Int J Cancer. 2014 Jan 1;134(1):174-80. (PMID: 23784625) ; Blood. 2007 Jul 15;110(2):695-708. (PMID: 17389762) ; Leukemia. 2007 Sep;21(9):2075-9. (PMID: 17508003) ; Blood. 2009 Jul 23;114(4):791-5. (PMID: 19182202) ; Nature. 2002 Dec 19-26;420(6917):860-7. (PMID: 12490959) ; Clin Gastroenterol Hepatol. 2008 Apr;6(4):451-8. (PMID: 18387498) ; Cancer Res. 2009 Aug 15;69(16):6482-9. (PMID: 19654312) ; Leukemia. 2005 Dec;19(12):2342-3. (PMID: 16224483) ; Semin Oncol. 2003 Apr;30(2):146-52. (PMID: 12720125) ; J Natl Cancer Inst. 2006 Jan 4;98(1):51-60. (PMID: 16391371) ; Blood. 2010 Nov 18;116(20):e90-8. (PMID: 20699439) ; N Engl J Med. 1992 Nov 19;327(21):1490-5. (PMID: 1383822)
  • Grant Information: N01-PC-67010 United States PC NCI NIH HHS; UL 1 RR024160 United States RR NCRR NIH HHS; N01-CP-ES-11027 United States CP NCI NIH HHS; CA143947 United States CA NCI NIH HHS; R01CA154643-01A1 United States CA NCI NIH HHS; N01-PC-67009 United States PC NCI NIH HHS; R01 CA92153 United States CA NCI NIH HHS; CA150037 United States CA NCI NIH HHS; K23 CA102216 United States CA NCI NIH HHS; R01CA45614 United States CA NCI NIH HHS; R01CA92153-S1 United States CA NCI NIH HHS; R01CA100555 United States CA NCI NIH HHS; CA62006 United States CA NCI NIH HHS; N01-PC-67008 United States PC NCI NIH HHS; N02-PC-71105 United States PC NCI NIH HHS; R01CA104682 United States CA NCI NIH HHS; N01-PC-65064 United States PC NCI NIH HHS; Canada CAPMC CIHR; P50 CA130805 United States CA NCI NIH HHS; R01CA122663 United States CA NCI NIH HHS; UL1 TR000135 United States TR NCATS NIH HHS; CA165923 United States CA NCI NIH HHS; United States ImNIH Intramural NIH HHS; 5R01 CA69669-02 United States CA NCI NIH HHS; T32 HL007152 United States HL NHLBI NIH HHS; CA51086 United States CA NCI NIH HHS; R03CA132153 United States CA NCI NIH HHS; R01 CA14690 United States CA NCI NIH HHS; R01CA087014 United States CA NCI NIH HHS; P50 CA97274 United States CA NCI NIH HHS; N01-CO-12400 United States CO NCI NIH HHS; U01 CA118444 United States CA NCI NIH HHS; R03CA125831 United States CA NCI NIH HHS; R01CA50850 United States CA NCI NIH HHS; N01-CP-95618 United States CP NCI NIH HHS
  • Entry Date(s): Date Created: 20140901 Date Completed: 20150522 Latest Revision: 20220331
  • Update Code: 20231215
  • PubMed Central ID: PMC4155457

Klicken Sie ein Format an und speichern Sie dann die Daten oder geben Sie eine Empfänger-Adresse ein und lassen Sie sich per Email zusenden.

oder
oder

Wählen Sie das für Sie passende Zitationsformat und kopieren Sie es dann in die Zwischenablage, lassen es sich per Mail zusenden oder speichern es als PDF-Datei.

oder
oder

Bitte prüfen Sie, ob die Zitation formal korrekt ist, bevor Sie sie in einer Arbeit verwenden. Benutzen Sie gegebenenfalls den "Exportieren"-Dialog, wenn Sie ein Literaturverwaltungsprogramm verwenden und die Zitat-Angaben selbst formatieren wollen.

xs 0 - 576
sm 576 - 768
md 768 - 992
lg 992 - 1200
xl 1200 - 1366
xxl 1366 -